Search results
Author(s):
Gheorghe-Andrei Dan
,
Antoni Martínez-Rubio
Added:
1 year ago
Author(s):
Ton Duy Mai
,
Tri Huynh Quang Ho
,
Sy Van Hoang
,
et al
Added:
1 year ago
Author(s):
Renato D Lopes
Added:
1 year ago
ESC Congress 24 — AF screening with a wearable ECG device increases diagnosis by over 50% but did not significantly reduce hospitalisation rates for stroke.We are joined onsite at ESC Congress 2024 by Dr Renato Lopes (Duke University Medical Center, NC) to discuss the findings from the GUARD-AF Trial (NCT04126486, Bristol-Myers Squibb), which was designed to determine if screening for undiagnosed…
View more
Author(s):
Manesh R Patel
,
Harriette Van Spall
Added:
1 year ago
ESC Congress 2024 — OCEANIC-AF was halted early due to a lack of efficacy in 2023. Investigators shared details of the trial at ESC, comparing asundexian against apixaban in patients with atrial fibrillation at risk of stroke.Host Dr Harriette Van Spall (McMaster University, Hamilton, Canada) sits down with primary investigator Dr Manesh R Patel (Duke University Health System, USA) to discuss the…
View more
Artificial Intelligence and AF
Author(s):
Davide Antonio Mei
,
Benedetta Cherubini
,
Jacopo Francesco Imberti
,
et al
Added:
1 month ago
Review Article
Author(s):
Kenneth Ellenbogen
Added:
1 year ago
A new policy statement released by HRS underscores the importance of continual training and education for electrophysiologists performing catheter ablation of atrial fibrillation (AF).In this short interview, Dr Kenneth Ellenbogen (VCU School of Medicine, US) discusses the key recommendations within this policy statement to ensure a strong electrophysiology base and skillset to achieve the best…
View more
Author(s):
Isabelle C Van Gelder
Added:
1 year ago
ESC Congress 2024 — Chair, Prof Isabelle C Van Gelder (University of Groningen, NL) joins us to discuss key highlights from the ESC Atrial Fibrillation 2024 guidelines.The new guidelines centre on shared and equal care, patient empowerment, comorbidities and risk factor management, and evidence-based management and re-evaluation. The new AF-CARE pathway integrates comorbidity management,…
View more
Author(s):
Dipak Kotecha
Added:
1 year ago
ESC Congress 2024 — Dr Dipak Kotecha (University of Birmingham, UK) joins us onsite in London to discuss key highlights from the ESC Atrial Fibrillation 2024 guidelines.Interview Questions:1. What is the prevalence of AF and the unmet needs of patients in 2024?2. What's new in the guidelines?3. What are some areas for improvement?4. What are some of the challenges and opportunities with the…
View more
Renal Impact: Rivaroxaban Versus Vitamin K Antagonists in AF
Author(s):
Phong Phan Dinh
,
Tri Huynh Quang Ho
,
Hung Manh Pham
,
et al
Added:
1 year ago
Systematic Review
Factor XIa Inhibitors’ Future Position in AF
Author(s):
Maki Komiyama
,
Moritake Iguchi
,
Hiromichi Wada
,
et al
Added:
1 year ago
Expert Opinion